62
A crucial step toward using genetics to inform more effective, personalized approaches for 63 treatment of individuals with ASD is to better understand how variation in implicated genes 64 influences expression of core symptoms and comorbidities. and others, have not observed a relationship between genetic and phenotypic differences (11, 12) . 75 As such, it is difficult to determine if distinguishing dysfunction across different underlying 76 biological processes is clinically useful. Notably, previous studies have focused largely on 77 evaluating contributions from specific types of genetic variants (e.g., solely de novo and rare 78 variants, or common variants) to explain phenotypic differences (11) (12) (13) (14) (15) (16) . A more holistic 79 approach that incorporates all relevant risk variation is better situated to ask how overall genetic 80 risk is related to particular symptom profiles that are unique to the individual (17, 18) . 81 Furthermore, to enable use of disparate genetic information in personalized medicine 82 approaches for ASD, ability to predict functional effects of a given variant on the ASD risk gene 83 and encoded protein is essential and may require functional analysis to test (19) . While functional 84 study of every suspected ASD risk variant is desirable in the long-term, reliance on such a 85 strategy is not feasible if genetic findings are to be rapidly translated in the clinic. It may be more 86 immediately useful to have computational approaches which incorporate evidence from multiple 87 sources to allow for more thorough in silico predictions from patient data to help pinpoint 88 specific genes and variants that should be prioritized for functional follow-up(20-22) . 89 To determine if current genetic evidence could help explain variability in ASD 90 symptoms, and ultimately inform treatment approaches, we developed an approach to calculate 91 the likelihood that a biological process with overrepresentation of ASD candidate genes is 92 dysfunctional. We evaluated the approach using whole-exome sequencing and phenotype data 93 from the Simons Simplex Collection (SSC) (23 Sanders et al., 2015(11) and Krumm et al., 2015(28) Gower dissimilarity matrices were calculated using correlation-based weights with the 'FD' processes. The genes that remained unassigned to any process were overrepresented in the 292 chromosome organization process (GO:0051276, p=7.10x10 -12 ; Fig. 1 , Table S1 ). An additional 293 82 genes were evidenced to be involved in chromosome organization. There were no unique 294 biological processes with evidence of overrepresentation for the remaining 507 unassigned ASD 295 candidate genes (Table S1 , Fig. S2 ). The overlap in ASD risk genes assigned the five 296 overrepresented biological processes representing unique terms is shown in Figure S3A . to be benign and inherited variants were more often predicted to be damaging if the consequence 306 related to a frameshift, splice-site alteration, or incorporation of a premature stop codon (Fig. 2) .
307
Screening data reported in previous studies(11, 28) for de novo and rare, inherited structural (Fig. S3B) . (Fig. 3A) . biological process had the strongest influence on the stability of the clusters (Fig. 3C) . Notably, 330 all of the individuals assigned to the smaller cluster had evidence of dysfunction in genes 331 involved in cognition ('cognition gene dysfunction cluster') while none of the individuals 332 assigned to the larger cluster had evidence for dysfunction in these genes (Fig. 3D) .
333

Three Cognition Genes are Associated with Distinct ASD Genetic Subgroup
334
Of the 61 cognition genes with likely damaging variants identified in the SSC dataset,
335
there were three genes (PTGS2, ABCA7, and SHANK3) that were strongly associated with 336 assignment to the cognition gene dysfunction cluster ( Table 1A, Table S6 ). reported by teachers on the SRS-TR and reduced IQs remained significant ( Fig 4A, Table S8A ).
360
Notably, both nonverbal and verbal IQ scores were lower in the genetic subgroup defined by 361 dysfunction in cognition genes ( Fig 4A, Table S8B ). Sex-stratified mean comparisons indicated 362 that differences between the genetic clusters for SRS-TR scores and verbal IQs were more 363 significant in males compared to females (Table S8C) . (Fig. 4B, Fig. S5 ). (Fig. 4B, Fig. S5 ). Full scale IQ scores were moderately correlated with scores for dexterity 376 (Purdue Pegboard Test, ρ =0.45; Fig 4C) and language acquisition (non-word repetition task, 377 ρ =0.48; Fig. 4C ) which were the 3 rd and 4 th largest contributors to PC1, respectively (Fig. S5) .
378
Of the top three genes associated with assignment to the 'cognition dysfunction cluster', 379 the stop-gain variant in the PTGS2 gene was associated with increased risk for having an IQ 380 score reflecting intellectual disability ( 
Evidence of Intra-Individual Genetic Dysfunction in Multiple Biological Processes
469
The majority of the evaluated individuals had a variant in an ASD candidate gene that 470 was predicted more often to be damaging compared to benign. By using these variants to 471 calculate dysfunction in overall biological processes, we also observed that the majority of 472 individuals had evidence of dysfunction in more than one process important to ASD etiology.
473
The unique terms that were selected reflect validations of results from previous studies observations are limited to teacher reports and do not extend to parent reports on the SRS-PR.
502
We observed weaker correlations between parent and teacher reports on the SRS than has been 503 previously reported(76). It is possible that these results reflect the highly variable symptom 504 severity of the subjects in the SSC as concordance between teacher and parent reports is 505 influenced by severity of ASD with higher concordance as ASD severity increases(77). 
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Figure Legends Shown is the distribution of significant terms in the GO structure for biological processes (GO:0008150). Terms highlighted in yellow indicate unique terms selected due to their place in the hierarchy and meaningfulness to ASD etiology. Terms highlighted in blue indicate significant processes considered too broad to be meaningful and green indicates significant child terms with complete genetic overlap to unique terms. Sig=the number of ASD candidate genes assigned to the process, Exp=the expected number of genes assigned by chance. *denotes terms that were significant at Fisher's exact FDR<1.0x10 -30 following the primary analysis of all 989 ASD risk genes, ** denotes terms that were significant at Fisher's exact FDR ranging from 3.5x10 -17 to 7.1x10 -12 following the secondary analysis run on genes unassigned to the top processes. Black lines connect terms that regulate each other, blue lines connect terms that are part of each other.
